Lilly, Novo Nordisk back direct-to-employer programs to expand access to weight-loss drugs – Reuters

1. Lilly, Novo Nordisk back direct-to-employer programs to expand access to weight-loss drugs  Reuters
2. Waltz Health Launches New Direct-to-Employer Access Model for Obesity Management Medications  PR Newswire
3. Novo Nordisk and Eli Lilly will offer Zepbound and Wegovy to companies starting Jan. 1 – Bloomberg News  MarketScreener
4. Novo, Lilly collaborate with Waltz Health to sell weight-loss drugs directly to employers  TradingView
5. Goodpath Expands Access to Obesity Management Care and Medications Through New Transparent Offering  PR Newswire

Continue Reading